Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines (Q31122902)

29 June 2017

title

Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines (English)

1 reference

29 June 2017

1 reference

1 reference

Arnould S

1

1 reference

29 June 2017

Hennebelle I

2

1 reference

29 June 2017

Canal P

3

1 reference

29 June 2017

Bugat R

4

1 reference

29 June 2017

Guichard S

5

1 reference

29 June 2017

publication date

1 January 2003

1 reference

European Journal of Cancer

29 June 2017

published in

1 reference

29 June 2017

volume

39

1 reference

29 June 2017

issue

1

1 reference

29 June 2017

page(s)

112-119

1 reference

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

In vitro studies on the mechanisms of oxaliplatin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

Biophysical analysis of DNA modified by 1,2-diaminocyclohexane platinum(II) complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

MutS preferentially recognizes cisplatin- over oxaliplatin-modified DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

48 Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

Intracellular glutathione and cytotoxicity of platinum complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

Mutations in XPA that prevent association with ERCC1 are defective in nucleotide excision repair

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

Differential oncogene amplification in tumor cells from a patient treated with cisplatin and 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900411-2

7 January 2021

10.1016/S0959-8049(02)00411-2

Identifiers

DOI

1 reference

29 June 2017

1 reference